NOV 17, 2022 3:00 AM PST

Anti-Aging Supplement Linked to Aggressive Breast Cancer

WRITTEN BY: Katie Kokolus

Vitamin B3, also known as niacin, is a generic name for a group of biochemical compounds, including nicotinamide riboside (NR).  Recent advances in biomedical research have focused on the clinical potential of NR as it restores cellular levels of an enzyme called nicotinamide adenine dinucleotide (NAD).  This essential mediator may protect against metabolic and age-related disorders.  Understanding the role of NAD in age-related diseases, and the ability of NR to increase NAD levels, has led to a plethora of NR products marketed as anti-aging and weight loss supplements. 

Clinicaltrials.gov lists over 40 ongoing clinical trials involving NR and its ability to modulate a wide range of diseases, including many cancers.  Some studies have shown NR as a safe supplement with minimal side effects.  Notably, NR is marketed as a supplement and has no therapeutic applications.  Much remains unknown about NR's role, particularly concerning how it interacts with different biological components within the body.

In an effort to better understand how different types of cells and tissues use NR, a group of researchers developed a new technique to visualize the enzyme as it travels throughout a living organism.  Their findings, recently published in Biosensors and Bioelectronics, raise some alarms about the long-term effects of NR use.

The researchers investigated how NR impacted cancer development in mouse models of triple-negative breast cancer (TNBC).  The researchers fed the mice NR-supplemented or normal food for two weeks prior to TNBC inoculation.  After ten weeks, tumor prevalence in the NR-supplemented mice exceeded that in the normal diet mice by 27%. 

As TNBC metastases to the brain, the researchers also investigated how NR impacted cancer spread to the brain.  Again, they found that NR-supplementation had detrimental effects.  Mice fed the NR-supplemented diet demonstrated a significantly increased the rate of metastatic spread to the brain.  The demonstration linking NR and brain metastasis is particularly alarming as TNBC patients who experience brain metastasis have a very poor prognosis and limited treatment options.

The authors concluded that their data shows that NR supplementation results in a significantly increased prevalence of TNBC and increases metastasis to the brain.  The manuscript also indicates that the researchers have ongoing work to decipher the precise mechanism by which NR fuels cancer growth and metastasis.  They note a hypothesis suggesting that NR could weaken the blood-brain barrier providing a pathway for cancer cells to get into the brain. 

 

Sources: Nutrients, Sci Rep, Biosensors and Bioelectronics, JAMA Network Open

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
SEP 26, 2022
Cancer
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
SEP 26, 2022
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus. ...
OCT 18, 2022
Immunology
Cell Adhesion Molecules in Immune and Cancer Therapy
OCT 18, 2022
Cell Adhesion Molecules in Immune and Cancer Therapy
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra ...
OCT 31, 2022
Cancer
Pumpkins: A Trick or a Treat for Cancer?
OCT 31, 2022
Pumpkins: A Trick or a Treat for Cancer?
Cancer is a disease that impacts the whole person, wreaking havoc on an individual’s emotional and physical well-b ...
OCT 21, 2022
Drug Discovery & Development
Gel-encased Radioactive Iodine Eliminates Pancreatic Cancer in Mice
OCT 21, 2022
Gel-encased Radioactive Iodine Eliminates Pancreatic Cancer in Mice
Researchers have developed a radioactive gel that eliminated pancreatic tumors in 80% of mice. The corresponding study w ...
NOV 14, 2022
Cancer
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
NOV 14, 2022
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
About 20% of breast cancers exhibit elevated levels of a protein known as HER2.  You may have heard the classifier ...
NOV 29, 2022
Drug Discovery & Development
Chemotherapy May Increase Disease Susceptibility for Two Generations
NOV 29, 2022
Chemotherapy May Increase Disease Susceptibility for Two Generations
A common chemotherapy drug may make future generations more susceptible to disease. The corresponding study was publishe ...
Loading Comments...